A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens - Archive ouverte HAL Access content directly
Journal Articles Nanomedicine: Nanotechnology, Biology and Medicine Year : 2023

A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens

Lidia Almenara-Fuentes
  • Function : Author
Miriam Salvado
  • Function : Author
Holger Bang
  • Function : Author
Marti Dalmases
  • Function : Author
Silvia Rodriguez-Vidal
  • Function : Author
Bruna Barneda-Zahonero
  • Function : Author

Abstract

Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of tissues by the host's immune system. Several antigen-specific immunotherapies, focused on arresting the autoimmune attack, have been tested in clinical trials with discouraging results. Therefore, there is a need for innovative strategies to restore self-tolerance safely and definitively in AIDs. We previously demonstrated the therapeutic efficacy of phosphatidylserine (PS)-liposomes encapsulating autoantigens in experimental type 1 diabetes and multiple sclerosis. Here, we show that PS-liposomes can be adapted to other autoimmune diseases by simply replacing the encapsulated autoantigen. After administration, they are distributed to target organs, captured by phagocytes and interact with several immune cells, thus exerting a tolerogenic and immunoregulatory effect. Specific PS-liposomes demonstrate great preventive and therapeutic efficacy in rheumatoid arthritis and myasthenia gravis. Thus, this work highlights the therapeutic potential of a platform for several autoimmunity settings, which is specific, safe, and with long-term effects.
Fichier principal
Vignette du fichier
68-Almenara Fuentes - Nanomedecine 2022.pdf (2.74 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive
Licence

Dates and versions

hal-03885962 , version 1 (17-11-2023)

Licence

Identifiers

Cite

Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
70 View
20 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More